Sentence: In recent years several tyrosine kinase inhibitors targeting specific molecular pathways involved in its pathogenesis have been investigated , such as sorafenib , lenvatinib , and sunitinib .
Drug combination annotation:
[{'class': 'POS', 'spans': ['sorafenib', 'sunitinib'], 'is_context_needed': True}]